1. Home
  2. TPCS vs OSTX Comparison

TPCS vs OSTX Comparison

Compare TPCS & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • OSTX
  • Stock Information
  • Founded
  • TPCS 1956
  • OSTX 2018
  • Country
  • TPCS United States
  • OSTX United States
  • Employees
  • TPCS N/A
  • OSTX N/A
  • Industry
  • TPCS Metal Fabrications
  • OSTX
  • Sector
  • TPCS Industrials
  • OSTX
  • Exchange
  • TPCS Nasdaq
  • OSTX NYSE
  • Market Cap
  • TPCS 42.6M
  • OSTX 43.0M
  • IPO Year
  • TPCS N/A
  • OSTX 2024
  • Fundamental
  • Price
  • TPCS $3.49
  • OSTX $1.81
  • Analyst Decision
  • TPCS
  • OSTX Strong Buy
  • Analyst Count
  • TPCS 0
  • OSTX 3
  • Target Price
  • TPCS N/A
  • OSTX $18.00
  • AVG Volume (30 Days)
  • TPCS 29.2K
  • OSTX 301.8K
  • Earning Date
  • TPCS 04-08-2025
  • OSTX 08-14-2025
  • Dividend Yield
  • TPCS N/A
  • OSTX N/A
  • EPS Growth
  • TPCS N/A
  • OSTX N/A
  • EPS
  • TPCS N/A
  • OSTX N/A
  • Revenue
  • TPCS $33,154,058.00
  • OSTX N/A
  • Revenue This Year
  • TPCS N/A
  • OSTX N/A
  • Revenue Next Year
  • TPCS N/A
  • OSTX N/A
  • P/E Ratio
  • TPCS N/A
  • OSTX N/A
  • Revenue Growth
  • TPCS 8.71
  • OSTX N/A
  • 52 Week Low
  • TPCS $2.05
  • OSTX $1.12
  • 52 Week High
  • TPCS $4.42
  • OSTX $7.00
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 45.47
  • OSTX N/A
  • Support Level
  • TPCS $3.21
  • OSTX N/A
  • Resistance Level
  • TPCS $3.43
  • OSTX N/A
  • Average True Range (ATR)
  • TPCS 0.21
  • OSTX 0.00
  • MACD
  • TPCS -0.08
  • OSTX 0.00
  • Stochastic Oscillator
  • TPCS 24.63
  • OSTX 0.00

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

About OSTX OS THERAPIES INCORPORATED

OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.

Share on Social Networks: